MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with P

Propylthiouracil

Propylthiouracil 25mg tablets

No stability information

Stability notes for Propylthiouracil 25mg tablets

There are no stability notes for this medicine.

Suppliers

Propylthiouracil 25mg tablets (A A H Pharmaceuticals Ltd)
Propylthiouracil 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Propylthiouracil 25mg tablets (Macleods Pharma UK Ltd)

Propylthiouracil 50mg tablets

Use with caution

Stability notes for Propylthiouracil 50mg tablets

Protect from light. Store in a well-closed container.

Provenance

This compatibility recommendation is derived from Propylthiouracil 50mg tablets (Wockhardt UK Ltd).

Suppliers (6) of Propylthiouracil 50mg tablets
Propylthiouracil 50mg tablets (A A H Pharmaceuticals Ltd)
Propylthiouracil 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Propylthiouracil 50mg tablets (Halewood Chemicals Ltd)
Propylthiouracil 50mg tablets (Macleods Pharma UK Ltd)
Propylthiouracil 50mg tablets (Medihealth (Northern) Ltd)
Propylthiouracil 50mg tablets (Morningside Healthcare Ltd)

Propylthiouracil 100mg tablets

No stability information

Stability notes for Propylthiouracil 100mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Propylthiouracil 100mg tablets
Propylthiouracil 100mg tablets (A A H Pharmaceuticals Ltd)
Propylthiouracil 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Propylthiouracil 100mg tablets (Macleods Pharma UK Ltd)
Propylthiouracil 100mg tablets (Morningside Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.